|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel RL, Fedewa SA, Anderson WF, Miller
KD, Ma J, Rosenberg PS and Jemal A: Colorectal cancer incidence
patterns in the United States, 1974-2013. J Natl Cancer Inst 109,
2017.
|
|
3
|
Zha F, Qu X, Tang B, Li J, Wang Y, Zheng
P, Ji T, Zhu C and Bai S: Long non-coding RNA MEG3 promotes
fibrosis and inflammatory response in diabetic nephropathy via
miR-181a/Egr-1/TLR4 axis. Aging (Albany NY). 11:3716–3730.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sato Y: The vasohibin family: A novel
family for angiogenesis regulation. J Biochem. 153:5–11.
2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li D, Zhou K, Wang S, Shi Z and Yang Z:
Recombinant adenovirus encoding vasohibin prevents tumor
angiogenesis and inhibits tumor growth. Cancer Sci. 101:448–452.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhao G, Yang Y, Tang Y, Han R and Sun Y:
Reduced expression of vasohibin-1 is associated with
clinicopathological features in renal cell carcinoma. Med Oncol.
29:3325–3334. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yan Y, Shen Z, Ye Y, Jiang K, Zhang H,
Shen C, Mustonen H, Puolakkainen P and Wang S: A novel molecular
marker of prognosis in colorectal cancer: Vasohibin-1. Med Oncol.
31(816)2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang H, Deng Q, Lv Z, Ling Y, Hou X, Chen
Z, Dinglin X, Ma S, Li D, Wu Y, et al: N6-methyladenosine induced
miR-143-3p promotes the brain metastasis of lung cancer via
regulation of VASH1. Mol Cancer. 18(181)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Heishi T, Hosaka T, Suzuki Y, Miyashita H,
Oike Y, Takahashi T, Nakamura T, Arioka S, Mitsuda Y, Takakura T,
et al: Endogenous angiogenesis inhibitor vasohibin1 exhibits
broad-spectrum antilymphangiogenic activity and suppresses lymph
node metastasis. Am J Pathol. 176:1950–1958. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Huang B, Huang M and Li Q:
Cancer-associated fibroblasts promote angiogenesis of
hepatocellular carcinoma by VEGF-Mediated EZH2/VASH1 pathway.
Technol Cancer Res Treat. 18(1533033819879905)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang B, Wu Z, Xie W, Tian D, Chen F, Qin
C, Du Z, Tang G, Gao Q, Qiu X, et al: The expression of vasohibin-1
and its prognostic significance in bladder cancer. Exp Ther Med.
14:3477–3484. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liu S, Han B, Zhang Q, Dou J, Wang F, Lin
W, Sun Y and Peng G: Vasohibin-1 suppresses colon cancer.
Oncotarget. 6:7880–7898. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
14
|
Zhang Y, Wang Q, Luo N, Liu J, Ren H, Shao
X, Zhang L and Yu Y: MicroRNA-1269a promotes proliferation and
arrest of apoptosis of glioma cells by directly targeting ATRX.
Front Oncol. 10(563901)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bu P, Wang L, Chen KY, Rakhilin N, Sun J,
Closa A, Tung KL, King S, Kristine Varanko A, Xu Y, et al: miR-1269
promotes metastasis and forms a positive feedback loop with TGF-β.
Nat Commun. 6(6879)2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jin RH, Yu DJ and Zhong M: MiR-1269a acts
as an onco-miRNA in non-small cell lung cancer via down-regulating
SOX6. Eur Rev Med Pharmacol Sci. 22:4888–4897. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li W, Zhang H, Min P, Zhu J, Xu D, Jiang
W, Ma Y, Qiu J, Xu W, Chen J, et al: Downregulated miRNA-1269a
variant (rs73239138) decreases the susceptibility to gastric cancer
via targeting ZNF70. Oncol Lett. 14:6345–6354. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guo C, Shi H, Shang Y, Zhang Y, Cui J and
Yu H: LncRNA LINC00261 overexpression suppresses the growth and
metastasis of lung cancer via regulating miR-1269a/FOXO1 axis.
Cancer Cell Int. 20(275)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hou JC, Xu Z, Zhong SL, Zhang HD, Jiang
LH, Chen X, Zhu LP, Li J, Zhou SY, Yang SJ, et al: Circular RNA
circASS1 is downregulated in breast cancer cells MDA-MB-231 and
suppressed invasion and migration. Epigenomics. 11:199–213.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang J, Luo X, Li H, Deng L and Wang Y:
Genome-wide uncovering of STAT3-mediated miRNA expression profiles
in colorectal cancer cell lines. Biomed Res Int.
2014(187105)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li XN, Wang ZJ, Ye CX, Zhao BC, Li ZL and
Yang Y: RNA sequencing reveals the expression profiles of circRNA
and indicates that circDDX17 acts as a tumor suppressor in
colorectal cancer. J Exp Clin Cancer Res. 37(325)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Han B, Chao J and Yao H: Circular RNA and
its mechanisms in disease: From the bench to the clinic. Pharmacol
Ther. 187:31–44. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liu J, Liu T, Wang X and He A: Circles
reshaping the RNA world: From waste to treasure. Mol Cancer.
16(58)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang HD, Jiang LH, Sun DW, Hou JC and Ji
ZL: CircRNA: A novel type of biomarker for cancer. Breast Cancer.
25:1–7. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang T, Wu DM, Deng SH, Han R, Liu T, Li
J and Xu Y: RNAseq profiling of circRNA expression in
radiation-treated A549 cells and bioinformatics analysis of
radiation-related circRNA-miRNA networks. Oncol Lett. 20:1557–1566.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Patop IL and Kadener S: circRNAs in
Cancer. Curr Opin Genet Dev. 48:121–127. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xu H, Liu Y, Cheng P, Wang C, Liu Y, Zhou
W, Xu Y and Ji G: CircRNA_0000392 promotes colorectal cancer
progression through the miR-193a-5p/PIK3R3/AKT axis. J Exp Clin
Cancer Res. 39(283)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Min P, Li W, Zeng D, Ma Y, Xu D, Zheng W,
Tang F, Chen J, Shi J, Hu H, et al: A single nucleotide variant in
microRNA-1269a promotes the occurrence and process of
hepatocellular carcinoma by targeting to oncogenes SPATS2L and
LRP6. Bull Cancer. 104:311–320. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu J and Dong YJ: Myocardial protective
effect and mechanism of dexmedetomidine on myocardial
ischemia-reperfusion injury in rats. Journal of Clinical and
Experimental Medicine. 17:2476–2479. 2018.(In Chinese).
|
|
32
|
Hu Y, Dingerdissen H, Gupta S, Kahsay R,
Shanker V, Wan Q, Yan C and Mazumder R: Identification of key
differentially expressed MicroRNAs in cancer patients through
pan-cancer analysis. Comput Biol Med. 103:183–197. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Miyashita H, Watanabe T, Hayashi H, Suzuki
Y, Nakamura T, Ito S, Ono M, Hoshikawa Y, Okada Y, Kondo T and Sato
Y: Angiogenesis inhibitor vasohibin-1 enhances stress resistance of
endothelial cells via induction of SOD2 and SIRT1. PLoS One.
7(e46459)2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shimizu K, Watanabe K, Yamashita H, Abe M,
Yoshimatsu H, Ohta H, Sonoda H and Sato Y: Gene regulation of a
novel angiogenesis inhibitor, vasohibin, in endothelial cells.
Biochem Biophys Res Commun. 327:700–706. 2005.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Takahashi Y, Saga Y, Koyanagi T, Takei Y,
Machida S, Taneichi A, Mizukami H, Sato Y, Matsubara S and Fujiwara
H: The angiogenesis regulator vasohibin-1 inhibits ovarian cancer
growth and peritoneal dissemination and prolongs host survival. Int
J Oncol. 47:2057–2063. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhao G, Na R, Li L, Xiao H, Ding N, Sun Y
and Han R: Vasohibin-1 inhibits angiogenesis and suppresses tumor
growth in renal cell carcinoma. Oncol Rep. 38:1021–1028.
2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang T, Jing L, Li H, Ding L, Ai D, Lyu J
and Zhong L: MicroRNA-4530 promotes angiogenesis by targeting VASH1
in breast carcinoma cells. Oncol Lett. 14:111–118. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tamaki K, Moriya T, Sato Y, Ishida T,
Maruo Y, Yoshinaga K, Ohuchi N and Sasano H: Vasohibin-1 in human
breast carcinoma: A potential negative feedback regulator of
angiogenesis. Cancer Sci. 100:88–94. 2009.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kanomata N, Sato Y, Miyaji Y, Nagai A and
Moriya T: Vasohibin-1 is a new predictor of disease-free survival
in operated patients with renal cell carcinoma. J Clin Pathol.
66:613–619. 2013.PubMed/NCBI View Article : Google Scholar
|
